Circulating soluble Fas ligand in patients with gastric carcinoma (Q73338920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Circulating soluble Fas ligand in patients with gastric carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

S Tsutsumi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Kuwano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Shimura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Morinaga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Mochiki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T Asao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

2560-2564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

Fas-mediated cytotoxicity by freshly isolated natural killer cells

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Fas ligand in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Elevated serum soluble Fas ligand in natural killer cell proliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Levels of soluble FasL and FasL gene expression during the development of graft-versus-host disease in DLT-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820001215%2989%3A12%3C2560%3A%3AAID-CNCR7%3E3.0.CO%3B2-Q

10.1002/1097-0142(20001215)89:12<2560::AID-CNCR7>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11135216%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference